|
1
|
Rawla P and Barsouk A: Epidemiology of
gastric cancer: Global trends, risk factors and prevention. Prz
Gastroenterol. 14:26–38. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
International Agency for Research on
Cancer; World Health Organization: World Source: Globocan 2020.
Available from: https://gco.iarc.fr/today/data/factsheets/populations/900-wolrd-fact-sheet.pdf.
Accessed on February 20, 2022.
|
|
3
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Castaneda CA, Castillo M, Chavez I,
Barreda F, Suarez N, Nieves J, Bernabe LA, Valdivia D, Ruiz E,
Dias-Neto E, et al: Prevalence of helicobacter pylori infection,
its virulent genotypes, and Epstein-Barr virus in peruvian patients
with chronic gastritis and gastric cancer. J Glob Oncol. 2019:1–9.
2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Nelen SD, Bosscha K, Lemmens VEPP,
Hartgrink HH, Verhoeven RHA and de Wilt JHW: Morbidity and
mortality according to age following gastrectomy for gastric
cancer. Br J Surg. 105:1163–1170. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Jeong JR, Choi JW, Ryu SY and Choe YR:
Relationship between frailty and mortality after gastrectomy in
older patients with gastric cancer. J Geriatr Oncol. 13:67–73.
2022.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Lee KG, Lee HJ, Yang JY, Oh SY, Bard S,
Suh YS, Kong SH and Yang HK: Risk factors associated with
complication following gastrectomy for gastric cancer:
Retrospective analysis of prospectively collected data based on the
Clavien-Dindo system. J Gastrointest Surg. 18:1269–1277.
2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
David H and Ilson MP: Microsatellite
instability: A biomarker in gastric cancer. NEJM J Watch: Sep 12,
2019 (Epub ahead of print).
|
|
9
|
Mohanty S, Rosenthal RA, Russell MM,
Neuman MD, Ko CY and Esnaola NF: Optimal perioperative management
of the geriatric patient: A best practices guideline from the
American college of surgeons NSQIP and the American geriatrics
society. J Am Coll Surg. 222:930–947. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Feldman AT and Wolfe D: Tissue processing
and hematoxylin and eosin staining. Methods Mol Biol. 1180:31–43.
2014.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Frampton GM, Fichtenholtz A, Otto GA, Wang
K, Downing SR, He J, Schnall-Levin M, White J, Sanford EM, An P, et
al: Development and validation of a clinical cancer genomic
profiling test based on massively parallel DNA sequencing. Nat
Biotechnol. 31:1023–1031. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
12
|
Choi YY, Kim H, Shin SJ, Kim HY, Lee J,
Yang HK, Kim WH, Kim YW, Kook MC, Park YK, et al: Microsatellite
instability and programmed cell death-ligand 1 expression in stage
II/III gastric cancer: Post hoc analysis of the classic randomized
controlled study. Ann Surg. 270:309–316. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Haag GM, Czink E, Ahadova A, Schmidt T,
Sisic L, Blank S, Heger U, Apostolidis L, Berger AK, Springfeld C,
et al: Prognostic significance of microsatellite-instability in
gastric and gastroesophageal junction cancer patients undergoing
neoadjuvant chemotherapy. Int J Cancer. 144:1697–1703.
2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Hashimoto T, Kurokawa Y, Takahashi T,
Miyazaki Y, Tanaka K, Makino T, Yamasaki M, Nakajima K, Ikeda JI,
Mori M and Doki Y: Predictive value of MLH1 and PD-L1 expression
for prognosis and response to preoperative chemotherapy in gastric
cancer. Gastric Cancer. 22:785–792. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kim SY, Choi YY, An JY, Shin HB, Jo A,
Choi H, Seo SH, Bang HJ, Cheong JH, Hyung WJ and Noh SH: The
benefit of microsatellite instability is attenuated by chemotherapy
in stage II and stage III gastric cancer: Results from a large
cohort with subgroup analyses. Int J Cancer. 137:819–825.
2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Smyth EC, Wotherspoon A, Peckitt C,
Gonzalez D, Hulkki-Wilson S, Eltahir Z, Fassan M, Rugge M, Valeri
N, Okines A, et al: Mismatch repair deficiency, microsatellite
instability, and survival: An exploratory analysis of the medical
research council adjuvant gastric infusional chemotherapy (MAGIC)
trial. JAMA Oncol. 3:1197–1203. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ellegren H: Microsatellites: Simple
sequences with complex evolution. Nat Rev Genet. 5:435–445.
2004.PubMed/NCBI View
Article : Google Scholar
|
|
18
|
Ratti M, Lampis A, Hahne JC, Passalacqua R
and Valeri N: Microsatellite instability in gastric cancer:
Molecular bases, clinical perspectives, and new treatment
approaches. Cell Mol Life Sci. 75:4151–4162. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Hudler P: Genetic aspects of gastric
cancer instability. ScientificWorldJournal.
2012(761909)2012.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Harfe BD and Jinks-Robertson S: DNA
mismatch repair and genetic instability. Annu Rev Genet.
34:359–399. 2000.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Genschel J, Littman SJ, Drummond JT and
Modrich P: Isolation of MutSbeta from human cells and comparison of
the mismatch repair specificities of MutSbeta and MutSalpha. J Biol
Chem. 273:19895–19901. 1998.PubMed/NCBI View Article : Google Scholar
|
|
22
|
De Wind N, Dekker M, Claij N, Jansen L,
van Klink Y, Radman M, Riggins G, van der Valk M, van't Wout K and
te Riele H: HNPCC-like cancer predisposition in mice through
simultaneous loss of Msh3 and Msh6 mismatch-repair protein
functions. Nat Genet. 23:359–362. 1999.PubMed/NCBI View
Article : Google Scholar
|
|
23
|
Miao HK, Chen LP, Cai DP, Kong WJ, Xiao L
and Lin J: MSH3 rs26279 polymorphism increases cancer risk: A
meta-analysis. Int J Clin Exp Pathol. 8:11060–11067.
2015.PubMed/NCBI
|
|
24
|
Ni H, Jiang B, Zhou Z, Yuan X, Cao X,
Huang G and Li Y: Inactivation of MSH3 by promoter methylation
correlates with primary tumor stage in nasopharyngeal carcinoma.
Int J Mol Med. 40:673–678. 2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Van Oers JMM, Edwards Y, Chahwan R, Zhang
W, Smith C, Pechuan X, Schaetzlein S, Jin B, Wang Y, Bergman A, et
al: The MutSβ complex is a modulator of p53-driven tumorigenesis
through its functions in both DNA double strand break repair and
mismatch repair. Oncogene. 33:3939–3946. 2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Haugen AC, Goel A, Yamada K, Marra G,
Nguyen TP, Nagasaka T, Kanazawa S, Koike J, Kikuchi Y, Zhong X, et
al: Genetic instability caused by loss of MutS homologue 3 in human
colorectal cancer. Cancer Res. 68:8465–8472. 2008.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Lee S, Chung H, Devaraj B, Iwaizumi M, Han
HS, Hwang DY, Seong MK, Jung BH and Carethers JM: Microsatellite
alterations at selected tetranucleotide repeats are associated with
morphologies of colorectal neoplasias. Gastroenterology.
139:1519–1525. 2010.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Wang K, Yuen ST, Xu J, Lee SP, Yan HHN,
Shi ST, Siu HC, Deng S, Chu KM, Law S, et al: Whole-genome
sequencing and comprehensive molecular profiling identify new
driver mutations in gastric cancer. Nat Genet. 46:573–582.
2014.PubMed/NCBI View
Article : Google Scholar
|
|
29
|
Guo YA, Chang MM, Huang W, Ooi WF, Xing M,
Tan P and Skanderup AJ: Mutation hotspots at CTCF binding sites
coupled to chromosomal instability in gastrointestinal cancers. Nat
Commun. 9(1520)2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhu L, Li Z, Wang Y, Zhang C, Liu Y and Qu
X: Microsatellite instability and survival in gastric cancer: A
systematic review and meta-analysis. Mol Clin Oncol. 3:699–705.
2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Seo JY, Jin EH, Jo HJ, Yoon H, Shin CM,
Park YS, Kim N, Jung HC and Lee DH: Clinicopathologic and molecular
features associated with patient age in gastric cancer. World J
Gastroenterol. 21:6905–6913. 2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Cancer Genome Atlas Research Network.
Comprehensive molecular characterization of gastric adenocarcinoma.
Nature. 513:202–209. 2014.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Angell HK, Lee J, Kim KM, Kim K, Kim ST,
Park SH, Kang WK, Sharpe A, Ogden J, Davenpor A, et al: PD-L1 and
immune infiltrates are differentially expressed in distinct
subgroups of gastric cancer. Oncoimmunology.
8(e1544442)2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
van Velzen MJM, Derks S, van Grieken NCT,
Mohammad NH and van Laarhoven HWM: MSI as a predictive factor for
treatment outcome of gastroesophageal adenocarcinoma. Cancer Treat
Rev. 86(102024)2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Garon EB, Rizvi NA, Hui R, Leighl N,
Balmanoukian AS, Eder JP, Patnaik A, Aggarwal C, Gubens M, Horn L,
et al: Pembrolizumab for the treatment of non-small-cell lung
cancer. N Engl J Med. 372:2018–2028. 2015.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Gogas H, Dréno B, Larkin J, Demidov L,
Stroyakovskiy D, Eroglu Z, Ferrucci PF, Pigozzo J, Rutkowski P,
Mackiewicz J, et al: Cobimetinib plus atezolizumab in
BRAFV600 wild-type melanoma: Primary results from the
randomized phase III IMspire170 study. Ann Oncol. 32:384–394.
2021.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Barroso-Sousa R, Keenan TE, Pernas S,
Exman P, Jain E, Garrido-Castro AC, Hughes M, Bychkovsky B, Umeton
R, Files JL, et al: Tumor mutational burden and PTEN alterations as
molecular correlates of response to PD-1/L1 blockade in metastatic
triple-negative breast cancer. Clin Cancer Res. 26:2565–2572.
2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Kim J, Kim B, Kang SY, Heo YJ, Park SH,
Kim ST, Kang WK, Lee J and Kim KM: Tumor mutational burden
determined by panel sequencing predicts survival after
immunotherapy in patients with advanced gastric cancer. Front
Oncol. 10(314)2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Rizzo A, Ricci AD and Brandi G: PD-L1,
TMB, MSI, and other predictors of response to immune checkpoint
inhibitors in biliary tract cancer. Cancers (Basel).
13(558)2021.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Kim JY, Kronbichler A, Eisenhut M, Hong
SH, van der Vliet HJ, Kang J, Shin JI and Gamerith G: Tumor
mutational burden and efficacy of immune checkpoint inhibitors: A
systematic review and meta-analysis. Cancers (Basel).
11(1798)2019.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Wang F, Wei XL, Wang FH, Xu N, Shen L, Dai
GH, Yuan XL, Chen Y, Yang SJ, Shi JH, et al: Safety, efficacy and
tumor mutational burden as a biomarker of overall survival benefit
in chemo-refractory gastric cancer treated with toripalimab, a PD-1
antibody in phase Ib/II clinical trial NCT02915432. Ann Oncol.
30:1479–1486. 2019.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Guo X, Liang X, Wang Y, Cheng A, Zhang H,
Qin C and Wang Z: Significance of tumor mutation burden combined
with immune infiltrates in the progression and prognosis of
advanced gastric cancer. Front Genet. 12(642608)2021.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Kim ST, Cristescu R, Bass AJ, Kim KM,
Odegaard JI, Kim K, Liu XQ, Sher X, Jung H, Lee M, et al:
Comprehensive molecular characterization of clinical responses to
PD-1 inhibition in metastatic gastric cancer. Nat Med.
24:1449–1458. 2018.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Takeda M, Takahama T, Sakai K, Shimizu S,
Watanabe S, Kawakami H, Tanaka K, Sato C, Hayashi H, Nonagase Y, et
al: Clinical application of the foundationone CDx assay to
therapeutic decision-making for patients with advanced solid
tumors. Oncologist. 26:e588–e596. 2021.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Sunami K, Ichikawa H, Kubo T, Kato M,
Fujiwara Y, Shimomura A, Koyama T, Kakishima H, Kitami M,
Matsushita H, et al: Feasibility and utility of a panel testing for
114 cancer-associated genes in a clinical setting: A hospital-based
study. Cancer Sci. 110:1480–1490. 2019.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Bilkey GA, Burns BL, Coles EP, Mahede T,
Baynam G and Nowak KJ: Optimizing precision medicine for public
health. Front Public Health. 7(42)2019.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Medrano-Guzmán R, Valencia-Mercado D,
Luna-Castillo M, García-Ríos LE and González-Rodríguez D:
Prognostic factors for survival in patients with resectable
advanced gastric adenocarcinoma. Cir Cir. 84:469–476.
2016.PubMed/NCBI View Article : Google Scholar : (In Spanish).
|
|
48
|
Garcia-Arispe JE, Loo-Valverde M, Chanduví
W, Vela-Ruiz JM, Guillen-Ponce R and Cruz-Vargas DL: Anemia y
supervivencia en pacientes con cáncer, un estudio peruano con
seguimiento de 5 años. Rev Fac Med Hum Enero. 21:90–100. 2021.(In
Spain).
|
|
49
|
Littlewood T: The impact of hemoglobin
levels on treatment outcomes in patients with cancer. Semin Oncol.
28:49–53. 2001.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Kim JJ, Tao H, Carloni E, Leung WK, Graham
DY and Sepulveda AR: Helicobacter pylori impairs DNA mismatch
repair in gastric epithelial cells. Gastroenterology. 123:542–553.
2002.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Silva-Fernandes IJDL, de Oliveira ES,
Santos JC, Ribeiro ML, Ferrasi AC, Pardini MI, Burbano RMR and
Rabenhorst SHB: The intricate interplay between MSI and
polymorphisms of DNA repair enzymes in gastric cancer H.pylori
associated. Mutagenesis. 32:471–478. 2017.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Machado AMD, Figueiredo C, Touati E,
Máximo V, Sousa S, Michel V, Carneiro F, Nielsen FC, Seruca R and
Rasmussen LJ: Helicobacter pylori infection induces genetic
instability of nuclear and mitochondrial DNA in gastric cells. Clin
Cancer Res. 15:2995–3002. 2009.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Koh FH, Chua JM, Tan JL, Foo FJ, Tan WJ,
Sivarajah SS, Ho LML, Teh BT and Chew MH: Paradigm shift in
gastrointestinal surgery-combating sarcopenia with prehabilitation:
Multimodal review of clinical and scientific data. World J
Gastrointest Surg. 13:734–755. 2021.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Kanda M: Preoperative predictors of
postoperative complications after gastric cancer resection. Surg
Today. 50:3–11. 2020.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Kanda M, Tanaka C, Murotani K, Kobayashi
D, Ito S, Mochizuki Y, Ishigure K, Ishiyama A, Teramoto H, Murai T,
et al: <Editors' Choice> Efficacy of enteral nutrients
containing β-hydroxy-β-methylbutyrate, glutamine, and arginine for
the patients with anastomotic leakage after gastrectomy: Study
protocol of a multicenter phase II clinical trial. Nagoya J Med
Sci. 80:351–355. 2018.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Sasahara M, Kanda M, Ito S, Mochizuki Y,
Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H,
et al: The preoperative prognostic nutritional index predicts
short-term and long-term outcomes of patients with stage II/III
gastric cancer: Analysis of a multi-institution dataset. Dig Surg.
37:135–144. 2020.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Xue DD, Cheng Y, Wu M and Zhang Y:
Comprehensive geriatric assessment prediction of postoperative
complications in gastrointestinal cancer patients: A meta-analysis.
Clin Interv Aging. 13:723–736. 2018.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Suwa K, Ushigome T, Ohtsu M, Narihiro S,
Ryu S, Shimoyama Y, Okamoto T and Yanaga K: Risk factors for early
postoperative small bowel obstruction after anterior resection for
rectal cancer. World J Surg. 42:233–238. 2018.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Barmparas G, Branco BC, Schnüriger B,
Oliver M, Konstantinidis A, Lustenberger T, Eberle BM, Inaba K and
Demetriades D: In-hospital small bowel obstruction after
exploratory laparotomy for trauma. J Trauma. 71:486–490.
2011.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Ellozy SH, Harris MT, Bauer JJ, Gorfine SR
and Kreel I: Early postoperative small-bowel obstruction: A
prospective evaluation in 242 consecutive abdominal operations. Dis
Colon Rectum. 45:1214–1217. 2002.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Khoraki J, Mazzini GS, Shah AS, Del Prado
PAR, Wolfe LG and Campos GM: Early small bowel obstruction after
laparoscopic gastric bypass: A surgical emergency. Surg Obes Relat
Dis. 14:1118–1125. 2018.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Nakamura T, Sato T, Naito M, Ogura N,
Yamanashi T, Miura H, Tsutsui A, Yamashita K and Watanabe M:
Laparoscopic surgery is useful for preventing recurrence of small
bowel obstruction after surgery for postoperative small bowel
obstruction. Surg Laparosc Endosc Percutan Tech. 26:e1–e4.
2016.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Badia-Tahull MB, Llop-Talaveron J,
Fort-Casamartina E, Farran-Teixidor L, Ramon-Torrel JM and
Jódar-Masanés R: Preoperative albumin as a predictor of outcome in
gastrointestinal surgery. E Spen Eur E J Clin Nutr Metab.
4:e248–e251. 2009.
|
|
64
|
Alberda C, Graf A and McCargar L:
Malnutrition: Etiology, consequences, and assessment of a patient
at risk. Best Pract Res Clin Gastroenterol. 20:419–439.
2006.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Morse BC, Simpson JP, Jones YR, Johnson
BL, Knott BM and Kotrady JA: Determination of independent
predictive factors for anastomotic leak: Analysis of 682 intestinal
anastomoses. Am J Surg. 206:950–956. 2013.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Meza JN, Ortiz FM and Segura ER: Hospital
malnutrition in a low-resources country: A survey and critique of
the status of the published available literature. Clin Nutr.
34:330–331. 2015.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Baca DA, Rego FR, Lazo MS, Rique IA and
Kano PL: Estado nutricional y morbi-mortalidad en pacientes con
anastomosis gastrointestinales en el hospital nacional hipolito
unanue (HNHU). Rev Gastroenterol Perú. 32:273–280. 2012.PubMed/NCBI
|
|
68
|
Robles Valcárcel P and Seclén MPT:
Nutritional status morbility and mortality in patients with
gastrointestinal anastomosis in the ‘Hospital Nacional Hipolito
Unanue’ (HNHU). Rev Gastroenterol Peru. 32:273–280. 2012.PubMed/NCBI(In Spanish).
|
|
69
|
Pinto JA, Pinillos L, Villarreal-Garza C,
Morante Z, Villarán MV, Mejía G, Caglevic C, Aguilar A, Fajardo W,
Usuga F, et al: Barriers in Latin America for the management of
locally advanced breast cancer. Ecancermedicalscience.
13(897)2019.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Li WH, Zhang JY, Liu WH and Chen XX: Role
of the initial degree of anaemia and treatment model in the
prognosis of gastric cancer patients treated by chemotherapy: A
retrospective analysis. BMC Cancer. 20(414)2020.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Puliga E, Corso S, Pietrantonio F and
Giordano S: Microsatellite instability in gastric cancer: Between
lights and shadows. Cancer Treat Rev. 95(102175)2021.PubMed/NCBI View Article : Google Scholar
|
